There’s a new layer of drug-industry middlemen that could drive up costs for patients


Welcome to Insider Healthcare. I’m healthcare editor Leah Rosenbaum, and today in healthcare news:

If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let’s get to it…

Medical medication medicine pharmacy pharmaceutical drugs pills vitamins cox prescription FDA over the counter OTC

Powerful drug-industry middlemen have quietly launched businesses to get better deals from drugmakers. It could drive up costs for patients.

Read our deep dive>>

David Liu
Beam Therapeutics cofounder David Liu. Jessica Rinaldi/The Boston Globe via Getty Images

As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer’s

Check it out>>

Patient and doctor.
Patient and doctor. Halfpoint / Getty Images

We asked major health systems to share the promising tech projects they are testing at hospitals. Here are 8 that are taking off.

See more>>

More stories we’re reading: